CDRO

Codere Online Luxembourg, S.A.

There isn't enough reported data to score CDRO yet.

NKE

NIKE, Inc.

60
Fundamentals56/ 100
Valuation80/ 100
Upside potential58/ 100
Risk potential18/ 100

NKE's fundamentals are mixed, but it looks cheap: trading at 18x earnings, below its usual 33x. Analysts expect earnings to hold roughly steady, though they disagree widely on how much.

CDRO Fundamentals

MetricStatus
Unavailable
Healthy
Unavailable
Unavailable

CDRO's profitability is currently healthy. There isn't enough data to rate its revenue, cash flow and balance sheet.

NKE Fundamentals

MetricStatus
Stable
Healthy
Stable
Strong

NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.

CDRO PE Valuation

CHEAPFAIREXPENSIVE26x51x77x102x
CHEAPFAIREXPENSIVE26x51x77x102x
LevelPEPriceVs current
Cheap72x$7.22-15%
Fair79x$7.94-7%
Current85x$8.54—
Expensive89x$8.89+4.1%

Historical ranges are pointers, not guarantees.

CDRO's PE is 85x, but its earnings don't support one, so it isn't a reliable read right now.

NKE PE Valuation

CHEAPFAIREXPENSIVE21x43x64x86x
CHEAPFAIREXPENSIVE21x43x64x86x
LevelPEPriceVs current
Current18x$37.76—
Cheap23x$47.70+26%
Forward30x$37.76—
Fair33x$68.16+80%
Expensive47x$97.86+159%

Historical ranges are pointers, not guarantees.

NKE has the edge over CDRO in the historical PE scenario, which offers more potential upside but is not a forecast.

CDRO Forward outlook

MetricOutlook
--
Strong growth
Growth
Strongly improving
Limited
Moderate

CDRO has the edge over NKE on the outlook, with more favorable earnings and revenue expectations.

NKE Forward outlook

MetricOutlook
Strongly deteriorating
Stable
Decline
Improving
Moderate
Low

Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.

CDRO Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $8.54 on Nov 12.

There is not enough scenario data to compare CDRO and NKE's risk to reward.

NKE Risk to reward

ScenarioChangePrice
Upside+25%$47.36
Downside-18%$30.83

Calculated from the latest close: $37.76 on Nov 12.

There is not enough scenario data to compare CDRO and NKE's risk to reward.

CDRO Earnings Per Share

Q4 2022: $-1.14Q4 2024: $0.10
Q4 2022: $-1.14Q4 2024: $0.10

CDRO and NKE do not have enough comparable growth data to identify a winner.

NKE Earnings Per Share

Q4 2023: $3.42Q1 2024: $3.40Q2 2024: $3.73Q3 2024: $3.49Q4 2024: $3.24Q1 2025: $3.01Q2 2025: $2.16Q3 2025: $1.95Q4 2025: $1.70Q1 2026: $1.51Q2 2026: $2.10Q3 2026: $2.09Forward: $1.27
Q4 2023: $3.42Q1 2024: $3.40Q2 2024: $3.73Q3 2024: $3.49Q4 2024: $3.24Q1 2025: $3.01Q2 2025: $2.16Q3 2025: $1.95Q4 2025: $1.70Q1 2026: $1.51Q2 2026: $2.10Q3 2026: $2.09Forward: $1.27
QuarterTTM EPSYoY
Forward$1.27-39%
Q3 2026$2.09+7.2%
Q2 2026$2.10-2.8%
Q1 2026$1.51-50%
Q4 2025$1.70-48%
Q3 2025$1.95-44%
Q2 2025$2.16-42%
Q1 2025$3.01-11%
Q4 2024$3.24-5.3%

NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.

CDRO Quarterly Revenue

Q1 2020: $19MQ2 2020: $15MQ3 2020: $23MQ4 2020: $23MQ4 2021: $89MQ4 2022: $129MQ1 2023: $41MQ2 2023: $41MQ4 2023: $97MQ1 2024: $57MQ2 2024: $57MQ4 2024: $110M
Q1 2020: $19MQ2 2020: $15MQ3 2020: $23MQ4 2020: $23MQ4 2021: $89MQ4 2022: $129MQ1 2023: $41MQ2 2023: $41MQ4 2023: $97MQ1 2024: $57MQ2 2024: $57MQ4 2024: $110M
QuarterRevenueYoY
Q4 2024$109.5M+13%
Q2 2024$56.7M+37%
Q1 2024$56.7M+37%
Q4 2023$96.7M-25%
Q4 2022$128.6M+44%
Q4 2021$89.2M+296%

CDRO has the edge over NKE in the latest year-over-year revenue comparison.

NKE Quarterly Revenue

Q4 2023: $13.4BQ1 2024: $12.4BQ2 2024: $12.6BQ3 2024: $11.6BQ4 2024: $12.4BQ1 2025: $11.3BQ2 2025: $11.1BQ3 2025: $11.7BQ4 2025: $12.4BQ1 2026: $11.3BQ2 2026: $11BQ3 2026: $11.2B
Q4 2023: $13.4BQ1 2024: $12.4BQ2 2024: $12.6BQ3 2024: $11.6BQ4 2024: $12.4BQ1 2025: $11.3BQ2 2025: $11.1BQ3 2025: $11.7BQ4 2025: $12.4BQ1 2026: $11.3BQ2 2026: $11BQ3 2026: $11.2B
QuarterRevenueYoY
Q3 2026$11.2B-4.3%
Q2 2026$11B-1.1%
Q1 2026$11.3B+0.1%
Q4 2025$12.4B+0.6%
Q3 2025$11.7B+1.1%
Q2 2025$11.1B-12%
Q1 2025$11.3B-9.3%
Q4 2024$12.4B-7.7%

NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.

CDRO Free Cash Flow

Q1 2020: $0Q2 2020: $0Q3 2020: $3MQ4 2020: $2MQ4 2021: --Q4 2022: --Q1 2023: −$4,140Q2 2023: −$4,140Q4 2023: --Q1 2024: −$243,843Q2 2024: −$243,843Q4 2024: --
Q1 2020: $0Q2 2020: $0Q3 2020: $3MQ4 2020: $2MQ4 2021: --Q4 2022: --Q1 2023: −$4,140Q2 2023: −$4,140Q4 2023: --Q1 2024: −$243,843Q2 2024: −$243,843Q4 2024: --
QuarterFree cash flowYoY
Q2 2024-$243.8K-$239.7K
Q1 2024-$243.8K-$239.7K

CDRO's free cash flow has turned negative after years in the green: −$495,966 over the past year.

NKE Free Cash Flow

Q4 2023: $2.6BQ1 2024: $1.9BQ2 2024: $2.4BQ3 2024: $274MQ4 2024: $920MQ1 2025: $1.7BQ2 2025: $363MQ3 2025: $15MQ4 2025: $386MQ1 2026: $284MQ2 2026: $1.5BQ3 2026: −$64M
Q4 2023: $2.6BQ1 2024: $1.9BQ2 2024: $2.4BQ3 2024: $274MQ4 2024: $920MQ1 2025: $1.7BQ2 2025: $363MQ3 2025: $15MQ4 2025: $386MQ1 2026: $284MQ2 2026: $1.5BQ3 2026: −$64M
QuarterFree cash flowYoY
Q3 2026-$64M-527%
Q2 2026$1.5B+313%
Q1 2026$284M-83%
Q4 2025$386M-58%
Q3 2025$15M-95%
Q2 2025$363M-85%
Q1 2025$1.7B-11%
Q4 2024$920M-65%

NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.

CDRO Total Shares

Q3 2020: 9MQ4 2020: 9MQ4 2021: 45MQ4 2022: 45MQ1 2023: 45MQ2 2023: 45MQ4 2023: 45MQ1 2024: 45MQ2 2024: 45MQ4 2024: 45M
Q3 2020: 9MQ4 2020: 9MQ4 2021: 45MQ4 2022: 45MQ1 2023: 45MQ2 2023: 45MQ4 2023: 45MQ1 2024: 45MQ2 2024: 45MQ4 2024: 45M
PeriodChange %Net change
Quarterly+0.1%+24K shares
1 year+0.5%+232K shares

CDRO has 45M diluted shares, up 0.5% from a year ago.

NKE Total Shares

Q4 2023: 1.5BQ1 2024: 1.5BQ2 2024: 1.5BQ3 2024: 1.5BQ4 2024: 1.5BQ1 2025: 1.5BQ2 2025: 1.5BQ3 2025: 1.5BQ4 2025: 1.5BQ1 2026: 1.5BQ2 2026: 1.5BQ3 2026: 1.5B
Q4 2023: 1.5BQ1 2024: 1.5BQ2 2024: 1.5BQ3 2024: 1.5BQ4 2024: 1.5BQ1 2025: 1.5BQ2 2025: 1.5BQ3 2025: 1.5BQ4 2025: 1.5BQ1 2026: 1.5BQ2 2026: 1.5BQ3 2026: 1.5B
PeriodChange %Net change
Quarterly+0.2%+3.2M shares
1 year+0.4%+5.2M shares
3 years-3.8%-59.1M shares
5 years-8.4%-135M shares
Available history-6.9%-110M shares

NKE has the edge over CDRO on shareholder dilution, with a more favorable share count trend.

CDRO Net Leverage

NKE Net Leverage

Q4 2023: 0.1xQ1 2024: -0.0xQ2 2024: -0.1xQ3 2024: 0.1xQ4 2024: 0.2xQ1 2025: 0.1xQ2 2026: 0.1xQ3 2026: 0.2x
Q4 2023: 0.1xQ1 2024: -0.0xQ2 2024: -0.1xQ3 2024: 0.1xQ4 2024: 0.2xQ1 2025: 0.1xQ2 2026: 0.1xQ3 2026: 0.2x
QuarterNet LeverageStatus
Q3 20260.2xVery low
Q2 20260.1xVery low
Q1 20250.1xVery low
Q4 20240.2xVery low
Q3 20240.1xVery low
Q2 2024-0.1xNet Cash
Q1 2024-0.0xVery low
Q4 20230.1xVery low

NKE's net debt is less than a year of its operating earnings (EBITDA).

CDRO Weekly Momentum

MetricValueStatus
RSI42.1Neutral
Stochastic15.8Oversold

CDRO's weekly RSI is 42 (neutral) and its Stochastic is 16 (oversold).

NKE Weekly Momentum

MetricValueStatus
RSI40.0Neutral
Stochastic57.5Neutral

NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).

CDRO PE vs Consumer Cyclical Sector

MetricCDROSector medianRelative
PE85x18x372% above
PE %655114 pts above

CDRO is trading at 85x earnings, a 372% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.

NKE PE vs Consumer Cyclical Sector

MetricNKESector medianRelative
PE18x18x0.3% above
PE %24745 pts below

NKE has the edge over CDRO on valuation relative to its sector.

CDRO Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$9.146.6% below
20 week MA$9.187% below
50 week MA$8.782.7% below
100 week MA$8.075.8% above
200 week MA$6.5730% above

CDRO has the edge over NKE on trend strength, trading above more of its moving averages.

NKE Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$36.72.8% above
20 week MA$39.23.6% below
50 week MA$48.021% below
100 week MA$58.435% below
200 week MA$79.252% below

NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.

CDRO Yearly ROI

YearStart priceEnd priceROI
2021$10.1$6.25-38%
2022$6.25$2.53-60%
2023$2.53$2.94+16%
2024$2.94$6.77+130%
2025$6.77$8.09+19%
2026 YTD$8.09$8.54+5.6%

CDRO has the edge over NKE on returns for 2026, with the stronger performance.

NKE Yearly ROI

YearStart priceEnd priceROI
2020$101.6$141.6+39%
2021$141.6$165.7+17%
2022$165.7$116.3-30%
2023$116.3$108.6-6.6%
2024$108.6$76.4-30%
2025$76.4$60.9-20%
2026 YTD$60.9$37.8-38%

NKE has finished four years in a row lower, and it's down 38% so far in 2026.

Give your agent the market.

Get API key